Licences for diacetylmorphine-assisted treatment

Diacetylmorphine-assisted treatment is governed specifically by the Narcotics Act (NarcA; RS 812.121) and is subject to a federal licensing system.

Article 3e, paragraph 1 of the NarcA specifies that the prescription, dispensing and administration of narcotics for purposes of treating persons with an addiction requires a cantonal licence. For diacetylmorphine-assisted treatment, it is necessary to obtain a federal licence in addition to the licence issued by the canton. The federal licence is issued by the FOPH.

Types of licence issued by the FOPH

An FOPH licence is required by:

  • The patient receiving the diacetylmorphine-assisted treatment;
  • The non-specialist institution where the patient wishing to continue the diacetylmorphine-assisted treatment is staying;
  • The physician prescribing the diacetylmorphine;
  • The institution providing the diacetylmorphine-assisted treatment.

Further information

Diacetylmorphine-assisted (heroin-assisted) treatment

Diacetylmorphine (pharmaceutical heroin) substitution treatment is intended for individuals with a severe heroin addiction. It is administered in specialist centres.

Last modification 06.08.2021

Top of page

Contact

Federal Office of Public Health FOPH
Prevention Non-communicable diseases Division
Schwarzenburgstrasse 157
3003 Berne
Switzerland
Tel. +41 58 463 20 43
E-mail

Print contact

https://www.bag.admin.ch/content/bag/en/home/gesetze-und-bewilligungen/gesuche-bewilligungen/ausnahmebewilligungen-bewilligungen-betmg/bewilligungen-hegebe.html